IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Spdr Series Trust S&P Biotech

Q3 2016 vs Q4 2016

Comparing institutional holders between quarters

Quarters

Q4 2016Q3 2016Q2 2016Q1 2016Q4 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Catawba Capital Management
UNCHANGED
Shares3,900 from 3,900
Change0 (0%)
Value$231 (-$28)
Filed 2017-01-12
Status
Catawba Capital Management
UNCHANGED3,9003,90000%$259$231-$282017-01-12
Showing 1 of 1 institutions